Difference between revisions of "Team:NUS Singapore/Parts"

Line 153: Line 153:
 
<p class="medium">RIOT RESPONDER</p>
 
<p class="medium">RIOT RESPONDER</p>
 
</header>
 
</header>
−
<p align=justify>NUS_Singapore is a start-up company formed by a group of undergraduates from the National University of Singapore (NUS), interested in developing new diagnostic tools for cancer using synthetic biology technology. Our start-up uses synthetic biological technology to create the Regulated Invasive Organism Targeting System (RIOT System) which consists of three components: The RIOT Sensor, RIOT Responder and the RIOT Invader. Taken together, this system employs a modular concept of integrating different genetic circuits that serve individual functions with crosstalk capability. For the full and detailed business plan of our start-up, please <a href="https://static.igem.org/mediawiki/2016/7/70/T--NUS_Singapore--BusinessPlanFinal.pdf" style="font-weight: bold;">CLICK HERE.</a></p><br/>
+
<p align=justify<style type="text/css">
 +
table.tableizer-table {
 +
font-size: 12px;
 +
border: 1px solid #CCC;
 +
font-family: Arial, Helvetica, sans-serif;
 +
}
 +
.tableizer-table td {
 +
padding: 4px;
 +
margin: 3px;
 +
border: 1px solid #CCC;
 +
}
 +
.tableizer-table th {
 +
background-color: #104E8B;
 +
color: #FFF;
 +
font-weight: bold;
 +
}
 +
</style>
 +
<table class="tableizer-table">
 +
<thead><tr class="tableizer-firstrow"><th>Part Number</th><th>Part Description</th><th>Characterised?</th><th>Link</th></tr></thead><tbody>
 +
<tr><td>BBa_K1897000</td><td>HasA coding sequence</td><td>Yes, in BBa_K1897001</td><td><a href="http://parts.igem.org/Part:BBa_ K1897000">http://parts.igem.org/Part:BBa_ K1897000</a></td></tr>
 +
<tr><td>BBa_K1897001</td><td>HasA expression unit</td><td>Yes</td><td><a href="http://parts.igem.org/Part:BBa_ K1897001">http://parts.igem.org/Part:BBa_ K1897001</a></td></tr>
 +
<tr><td></td><td></td><td>Yes, in BBa_K1897007</td><td><a href="">http://parts.igem.org/Part:BBa_ K1897002</a></td></tr>
 +
<tr><td>BBa_K1897003</td><td>HasS coding sequence</td><td>Yes, in BBa_K1897007</td><td><a href="http://parts.igem.org/Part:BBa_ K1897003">http://parts.igem.org/Part:BBa_ K1897003</a></td></tr>
 +
<tr><td>BBa_K1897005</td><td>HasI coding sequence </td><td>Yes, in BBa_K1897007</td><td><a href="http://parts.igem.org/Part:BBa_ K1897005">http://parts.igem.org/Part:BBa_ K1897005</a></td></tr>
 +
<tr><td></td><td></td><td>Yes, in BBa_K1897007</td><td><a href="http://parts.igem.org/Part:BBa_ K1897006">http://parts.igem.org/Part:BBa_ K1897006</a></td></tr>
 +
<tr><td>BBa_K1897007</td><td>Complete Has operon (controlling expression of LuxR)</td><td>Yes</td><td><a href="http://parts.igem.org/Part:BBa_ K1897007">http://parts.igem.org/Part:BBa_ K1897007</a></td></tr>
 +
</tbody></table></p><br/>
 
 
 
<hr/>
 
<hr/>

Revision as of 04:13, 18 October 2016


Interactive Points | Codrops

iGEM 2016         NUS SINGAPORE

Parts Registry

RIOT Sensor

Part NumberPart DescriptionCharacterised?Link
BBa_K1897019p70-34-ALR-Terminator Yeshttp://parts.igem.org/Part:BBa_K1897019
BBa_K1897020p70-32-ALR-Terminator Yeshttp://parts.igem.org/Part:BBa_K1897020
BBa_K1897021p70-33-ALR-Terminator Yeshttp://parts.igem.org/Part:BBa_K1897021
BBa_K1897022p62-34-ALR-Terminator Yeshttp://parts.igem.org/Part:BBa_K1897022
BBa_K1897023p62-32-ALR-Terminator Yeshttp://parts.igem.org/Part:BBa_K1897023
BBa_K1897024p62-33-ALR-Terminator Yeshttp://parts.igem.org/Part:BBa_K1897024
BBa_K1897025J23100-34-ALR-Terminator Yeshttp://parts.igem.org/Part:BBa_K1897025
BBa_K1897026J23100-32-ALR-Terminator Yeshttp://parts.igem.org/Part:BBa_K1897026
BBa_K1897027J23100-33-ALR-Terminator Yeshttp://parts.igem.org/Part:BBa_K1897027
BBa_K1897028p70-33-sfGFP-Terminator Yeshttp://parts.igem.org/Part:BBa_K1897028
BBa_K1897029p62-33-sfGFP-Terminator Yeshttp://parts.igem.org/Part:BBa_K1897029

RIOT RESPONDER

table.tableizer-table { font-size: 12px; border: 1px solid #CCC; font-family: Arial, Helvetica, sans-serif; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #CCC; } .tableizer-table th { background-color: #104E8B; color: #FFF; font-weight: bold; }

Part NumberPart DescriptionCharacterised?Link
BBa_K1897000HasA coding sequenceYes, in BBa_K1897001http://parts.igem.org/Part:BBa_ K1897000
BBa_K1897001HasA expression unitYeshttp://parts.igem.org/Part:BBa_ K1897001
Yes, in BBa_K1897007http://parts.igem.org/Part:BBa_ K1897002
BBa_K1897003HasS coding sequenceYes, in BBa_K1897007http://parts.igem.org/Part:BBa_ K1897003
BBa_K1897005HasI coding sequence Yes, in BBa_K1897007http://parts.igem.org/Part:BBa_ K1897005
Yes, in BBa_K1897007http://parts.igem.org/Part:BBa_ K1897006
BBa_K1897007Complete Has operon (controlling expression of LuxR)Yeshttp://parts.igem.org/Part:BBa_ K1897007


RIOT Invader

In cancer treatment, specificity, sensitivity and reliability of diagnosis is the gold criteria of any diagnostic method. The RIOT System employs a novel method of cancer detection, relying on spatial markers that are intrinsic to the tumour microenvironment. Two types of spatial markers are used to increase specificity and ensure that only cancerous cells are targeted. The first spatial marker would be the elevated concentration of lactate usually found around tumours due to the Warburg effect. The second marker would be the detection of CD44v6, a cell surface marker that is upregulated on a variety of cancers. These spatial markers were specially chosen to circumvent a common problem in cancer research, where heterogeneity in different types of cancers results in the lack of a specific diagnostic for a variety of cancers. As elevated lactate concentration is ubiquitous among solid tumours and CD44v6 is present in different types of cancers, our RIOT System has the potential to be a diagnostic that can be applied to multiple cancers, which is advantageous in the current market where broad spectrum diagnostics for cancer are currently lacking. Furthermore, the utility of RIOT System can extend beyond just being a diagnostic and can be modified to deliver a drug payload, potentially acting as both a diagnostic and therapeutic.


Based on our preliminary market analysis of the diagnostics industry, our proposed RIOT System stands out as one of the few in vivo options available for cancer detection. Current cancer diagnostics rely mainly on in vitro laboratory tests for detection of cancer biomarkers (e.g. blood, urine), imaging scans (e.g. CT scans, MRI) or physical examinations to detect the tumour. Thus, our RIOT System offers a radically different diagnostic option that sets itself apart from the current diagnostics.


  • © NUS_Singapore iGEM 2016
Go To Top